H-Cyte, Inc. engages in the design and marketing of proprietary medical devices for commercial use in the United States and Europe. It offers DenerveX device, which provides pain relief from facet joint syndrome. The company was founded by Scott M. W. Haufe and Steven Gorlin on July 30, 2013 and is headquartered in Tampa, FL.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$19.95    OTCQB
As of 07/01/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  02/02/2015
Outstanding shares:  255,087,503
Average volume:  7,361
Market cap:   $5,101,750
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy